pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
KER-0193
Fragile X Syndrome
Kaerus Bioscience Ltd
0
catalysts
Preclinical
KFPH-013
Unspecified Cancer
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Preclinical
KFPH-015
Influenzavirus A Infections
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Preclinical
KFPH-020
Hypercholesterolemia
← prev
page 100 of 231
next →
131
Pain
89
Neurology
1
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Phase 1
KGX-101
Solid Tumor
Shanghai KangaBio Co Ltd
0
catalysts
Preclinical
KIN-102
Solid Tumor
Kinimmune Inc
0
catalysts
Phase 1
KINE-101A
Rheumatoid Arthritis
Kine Sciences
0
catalysts
KISQALI FEMARA CO-PACK
KISQALI FEMARA CO-PACK (LETROZOLE AND RIBOCICLIB)
NOVARTIS
0
catalysts
KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE
KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE (TECHNETIUM TC99M PYROPHOSPHATE)
SUN PHARM INDS INC
0
catalysts
Preclinical
KIT-20
Subacute Necrotizing Encephalomyelopathy (Leigh Disease)
Neurocores Inc
0
catalysts
Phase 2
KITE-363
Diffuse Large B-Cell Lymphoma
Kite Pharma Inc
0
catalysts
Phase 2
KITE-753
Diffuse Large B-Cell Lymphoma
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 1
KK-2269
Solid Tumor
Kyowa Kirin Co Ltd
0
catalysts
Phase 2
KK-8123
X-Linked Hypophosphatemic Rickets
Kyowa Kirin Co Ltd
0
catalysts
Phase 2
KL4 Surfactant
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Windtree Therapeutics Inc
0
catalysts
KLAYESTA
KLAYESTA (NYSTATIN TOPICAL POWDER)
Epic Pharma LLC
0
catalysts
Preclinical
KLS-13019
Hepatic Encephalopathy
Neuropathix Inc
0
catalysts
Preclinical
KLS-13023
Traumatic Brain Injury
Neuropathix Inc
0
catalysts
Phase 2
KLS-2031
Neuropathic Pain (Neuralgia)
Kolon Life Science Inc
0
catalysts
Preclinical
KLS-3021
Breast Cancer
Kolon Life Science Inc
0
catalysts
Preclinical
KLTO-202
Amyotrophic Lateral Sclerosis
Klotho Neurosciences Inc
0
catalysts
Phase 1
KM-023
Unspecified Genetic Disorders
Orvida Pharma Ltd
0
catalysts
Phase 2
KM-819
Parkinson's Disease
Fascinate Therapeutics Inc
0
catalysts
Preclinical
KMD-111
Breast Cancer
KMD Bio Co Ltd
0
catalysts
Phase 1
KN-01
Breast Cancer
PendreaBio Inc
0
catalysts
Preclinical
KOP-101
Prostate Cancer
KOP Therapeutics Corp
0
catalysts
Phase 2
KP-1077
serdexmethylphenidate
Idiopathic Hypersomnia (IH)
Sodium-dependent dopamine transporter
Sodium-dependent noradrenaline transporter
$ZVRA
ZEVRA THERAPEUTICS, INC.
0
catalysts
Phase 1
KPG-121
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Kangpu Biopharmaceuticals Ltd
0
catalysts
Phase 3
KPL-387
Pericarditis
$KNSA
Kiniksa Pharmaceuticals International, plc
0
catalysts
Preclinical
KPV
Inflammation
PharmaTher Holdings Ltd
0
catalysts
